Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoids down-regulate dendritic cell function in vitro and in vivo

M Moser1, T De Smedt, T Sornasse

  • 1Département de Biologie Moléculaire, Université Libre de Bruxelles, Rhode-Saint-Genèse, Belgium.

European Journal of Immunology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous approach for inframammary fold creation combined with exclusive adipose tissue transfer in post-mastectomy breast reconstruction.

Annales de chirurgie plastique et esthetique·2025
Same author

[Local administration of amphotericin B by VAC instillation: Therapeutic aid in the treatment of mucormycosis].

Annales de chirurgie plastique et esthetique·2023
Same author

Investigation of inflammatory and allergic responses to common mold species: Results from in vitro experiments, from a mouse model of asthma, and from a group of asthmatic patients.

Indoor air·2017
Same author

Maintenance of B cells during chronic murine Trypanosoma brucei gambiense infection.

Parasite immunology·2016
Same author

In vivo characterization of two additional Leishmania donovani strains using the murine and hamster model.

Parasite immunology·2016
Same author

Some thoughts on idiotypic networks and immunoregulation.

Immunology today·2014

Glucocorticoids, like dexamethasone, impair dendritic cell (DC) function. This study shows these hormones reduce DC viability and co-stimulatory molecule expression, impacting T cell activation and immune responses.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Glucocorticoids are used therapeutically and act as endogenous immunosuppressants.
  • T cell activation requires antigen presentation and co-stimulatory signals from antigen-presenting cells.
  • Dendritic cells (DCs) are crucial for initiating primary immune responses by activating naive T cells.

Purpose of the Study:

  • To investigate the effect of glucocorticoids on the capacity of dendritic cells (DCs) to sensitize naive T cells.
  • To determine how dexamethasone influences DC viability, co-stimulatory molecule expression, and immunostimulatory properties.

Main Methods:

  • In vitro experiments assessing dexamethasone's impact on DC viability and co-stimulatory molecule expression.
  • In vivo studies evaluating dexamethasone's effect on antigen-presenting function and splenic DC numbers after a single injection.

Related Experiment Videos

Main Results:

  • Dexamethasone (Dex) reduced the viability of DCs in vitro.
  • Dex selectively down-regulated co-stimulatory molecules on viable DCs, significantly reducing their immunostimulatory capacity.
  • In vivo, a single Dex injection impaired DC antigen presentation and reduced splenic DC numbers.

Conclusions:

  • Glucocorticoids regulate DC maturation and immune function both in vitro and in vivo.
  • This regulation by glucocorticoids may serve as a mechanism to prevent immune system overstimulation.
  • The findings highlight the role of glucocorticoids in modulating immune responses through dendritic cell function.